The related miRNAs involved in doxorubicin resistance or sensitivity of various cancers: an update
Sign Up to like & getrecommendations! Published in 2021 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-021-04337-8
Abstract: Doxorubicin (DOX) is an effective chemotherapy agent against a wide variety of tumors. However, intrinsic or acquired resistance diminishes the sensitivity of cancer cells to DOX, which leads to a cancer relapse and treatment failure.… read more here.
Keywords: dox sensitivity; sensitivity; resistance; cancer ... See more keywords